<aside> <img src="/icons/info-alternate_green.svg" alt="/icons/info-alternate_green.svg" width="40px" /> Transforming colorectal cancer screening through vertical AI agents that close the compliance gap and improve outcomes.
</aside>
Despite colorectal cancer being highly preventable with proper screening, approximately one-third of eligible patients never receive their recommended screenings. This compliance gap leads to later-stage diagnoses, poorer outcomes, missed revenue for health systems, and lower quality metrics scores. Current outreach methods are manual, inconsistent, and unable to effectively scale to address individual patient barriers.
Colorectal cancer is the second leading cause of cancer deaths in the United States, yet it's up to 90% preventable with proper screening. Each missed screening represents both a potential life at risk and a financial loss for healthcare systems. As value-based care models expand, screening compliance directly impacts reimbursement rates and quality rankings.
Galen Health deploys specialized AI agents that improve improve rates of patient screening compliance. Our vertical AI agents start by analyzing EHR data to precisely identify patients who are missing their recommended colorectal cancer screenings. Once these patients are identified, our agents automate the entire care gap closure process—from personalized outreach and scheduling to reminders and follow-up—removing friction points that typically prevent patients from completing their screenings.
Our base-plus pricing model aligns our success with yours. We charge a baseline fee of $1 per patient in your population, with performance incentives tied directly to increased screening compliance. Our customers only pay premium fees when we deliver measurable results – more completed screenings.
Our AI agents seamlessly integrate with your existing EHR system to: